About
Digital Diagnostics is a healthcare technology company focused on developing and implementing artificial intelligence (AI) diagnostic systems. Founded by Dr. Michael Abramoff, the company aims to enhance healthcare quality, accessibility, and affordability globally. It is known for its autonomous AI platforms that can make clinical decisions independently, improving patient outcomes and democratizing healthcare. The flagship product, LumineticsCore®, is an FDA-authorized AI system that diagnoses diabetic retinopathy and diabetic macular edema at the point-of-care without needing physician input. This system analyzes retinal images to detect diabetes-related eye diseases, facilitating earlier diagnosis and treatment. Digital Diagnostics also offers integration services for electronic medical records and collaborates with healthcare providers to establish AI diagnosis as a new standard of care. The company emphasizes ethical AI development, prioritizing safety, equity, and accessibility. Its mission is to make healthcare more accessible and affordable while improving the quality of care through innovative AI solutions.
Technologies
Keywords
Company Information
-
Employees 110
-
Founded 2010
-
Annual Revenue $13200000
-
Total Funding $177236498
Location
210 5th St, Coralville, Iowa, United States, 52241-2425
